Table of Contents

Global Vaccines & Vaccination Market Segment Research Report 2022

1. Research Scope

2. Market Overview

• 2.1 Product Introduction, Application, Picture
• 2.2 Global Vaccines & Vaccination Market by Value
  • 2.2.1 Global Vaccines & Vaccination Revenue by Type
  • 2.2.2 Global Vaccines & Vaccination Market by Value (%)
• 2.3 Global Vaccines & Vaccination Market by Production
  • 2.3.1 Global Vaccines & Vaccination Production by Type
  • 2.3.2 Global Vaccines & Vaccination Market by Production (%)

3. The Major Driver of Vaccines & Vaccination Industry

• 3.1 Historical & Forecast Global Vaccines & Vaccination Demand
• 3.2 Largest Application for Vaccines & Vaccination (2018-2028)
• 3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Vaccines & Vaccination Market

• 4.1 Regional Market Size in Terms of Production & Demand (2022)
• 4.2 Regional Market Share in Terms of Revenue (2018-2022)
• 4.3 Concentration Ratio (CR5& CR10) of Vaccines & Vaccination Market
• 4.4 Mergers & Acquisitions, Expansion Plans

5. US Vaccines & Vaccination Production, Demand (2018-2028)

• 5.1 Current and Estimated Production Breakdown by Type
• 5.2 Current and Estimated Demand Breakdown by Type
• 5.3 Current and Estimated Demand Breakdown by Application
• 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
• 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Vaccines & Vaccination Production, Demand (2018-2028)

• 6.1 Current and Estimated Production Breakdown by Type
• 6.2 Current and Estimated Demand Breakdown by Type
• 6.3 Current and Estimated Demand Breakdown by Application
• 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
• 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Vaccines & Vaccination Production, Demand (2018-2028)

• 7.1 Current and Estimated Production Breakdown by Type
• 7.2 Current and Estimated Demand Breakdown by Type
• 7.3 Current and Estimated Demand Breakdown by Application
• 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
• 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Vaccines & Vaccination Production, Demand (2018-2028)

• 8.1 Current and Estimated Production Breakdown by Type
• 8.2 Current and Estimated Demand Breakdown by Type
• 8.3 Current and Estimated Demand Breakdown by Application
• 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
• 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Vaccines & Vaccination Production, Demand (2018-2028)

• 9.1 Current and Estimated Production Breakdown by Type
• 9.2 Current and Estimated Demand Breakdown by Type
• 9.3 Current and Estimated Demand Breakdown by Application
• 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
• 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Vaccines & Vaccination Production, Demand (2018-2028)

• 10.1 Current and Estimated Production Breakdown by Type
• 10.2 Current and Estimated Demand Breakdown by Type
• 10.3 Current and Estimated Demand Breakdown by Application
• 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
• 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Vaccines & Vaccination Production, Demand (2018-2028)

• 11.1 Current and Estimated Production Breakdown by Type
• 11.2 Current and Estimated Demand Breakdown by Type
• 11.3 Current and Estimated Demand Breakdown by Application
• 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
• 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Vaccines & Vaccination Average Price Trend

• 12.1 Market Price for Each Type of Vaccines & Vaccination in US (2018-2022)
• 12.2 Market Price for Each Type of Vaccines & Vaccination in Europe (2018-2022)
• 12.3 Market Price for Each Type of Vaccines & Vaccination in China (2018-2022)
• 12.4 Market Price for Each Type of Vaccines & Vaccination in Japan (2018-2022)
• 12.5 Market Price for Each Type of Vaccines & Vaccination in India (2018-2022)
• 12.6 Market Price for Each Type of Vaccines & Vaccination in Korea (2018-2022)
• 12.7 Market Price for Each Type of Vaccines & Vaccination in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)

• 13.1 Vaccines & Vaccination Industrial Chain Analysis
• 13.2 Downstream
• 13.3 Impact of COVID-19
• 13.4 Post-pandemic Era
• 13.5 Technology Trends of Vaccines & Vaccination

14. Vaccines & Vaccination Competitive Landscape

• 14.1 Abbott
  • 14.1.1 Abbott Company Profiles
  • 14.1.2 Abbott Product Introduction
  • 14.1.3 Abbott Vaccines & Vaccination Sales, Revenue (2018-2022)
  • 14.1.4 Strategic initiatives
• 14.2 AstraZeneca
  • 14.2.1 AstraZeneca Company Profiles
  • 14.2.2 AstraZeneca Product Introduction
  • 14.2.3 AstraZeneca Vaccines & Vaccination Sales, Revenue (2018-2022)
  • 14.2.4 Strategic initiatives
• 14.3 Bavarian Nordic
  • 14.3.1 Bavarian Nordic Company Profiles
  • 14.3.2 Bavarian Nordic Product Introduction
  • 14.3.3 Bavarian Nordic Vaccines & Vaccination Sales, Revenue (2018-2022)
  • 14.3.4 Strategic initiatives
• 14.4 Novartis
  • 14.4.1 Novartis Company Profiles
  • 14.4.2 Novartis Product Introduction
  • 14.4.3 Novartis Vaccines & Vaccination Sales, Revenue (2018-2022)
  • 14.4.4 Strategic initiatives
• 14.5 Bharat Biotech
  • 14.5.1 Bharat Biotech Company Profiles
  • 14.5.2 Bharat Biotech Product Introduction
  • 14.5.3 Bharat Biotech Vaccines & Vaccination Sales, Revenue (2018-2022)
  • 14.5.4 Strategic initiatives
• 14.6 Bio-Med
  • 14.6.1 Bio-Med Company Profiles
  • 14.6.2 Bio-Med Product Introduction
  • 14.6.3 Bio-Med Vaccines & Vaccination Sales, Revenue (2018-2022)
  • 14.6.4 Strategic initiatives
• 14.7 CSL
  • 14.7.1 CSL Company Profiles
  • 14.7.2 CSL Product Introduction
  • 14.7.3 CSL Vaccines & Vaccination Sales, Revenue (2018-2022)
  • 14.7.4 Strategic initiatives
• 14.8 Emergent BioSolutions
  • 14.8.1 Emergent BioSolutions Company Profiles
  • 14.8.2 Emergent BioSolutions Product Introduction
  • 14.8.3 Emergent BioSolutions Vaccines & Vaccination Sales, Revenue (2018-2022)
  • 14.8.4 Strategic initiatives
• 14.9 GSK
  • 14.9.1 GSK Company Profiles
  • 14.9.2 GSK Product Introduction
  • 14.9.3 GSK Vaccines & Vaccination Sales, Revenue (2018-2022)
  • 14.9.4 Strategic initiatives
• 14.10 Johnson & Johnson
  • 14.10.1 Johnson & Johnson Company Profiles
  • 14.10.2 Johnson & Johnson Product Introduction
  • 14.10.3 Johnson & Johnson Vaccines & Vaccination Sales, Revenue (2018-2022)
  • 14.10.4 Strategic initiatives
• 14.11 Pfizer
• 14.12 Merck
• 14.13 Sanofi

15. Conclusion

16. Methodology and Data Source

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Vaccines & Vaccination Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Vaccines & Vaccination industry at home and abroad, estimate the overall market scale of the Vaccines & Vaccination industry and the market share of major countries, Vaccines & Vaccination industry, and study and judge the downstream market demand of Vaccines & Vaccination through systematic research, Analyze the competition pattern of Vaccines & Vaccination, so as to help solve the pain points of various stakeholders in Vaccines & Vaccination industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Vaccines & Vaccination Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Vaccines & Vaccination Market?
Abbott
AstraZeneca
Bavarian Nordic
Novartis
Bharat Biotech
Bio-Med
CSL
Emergent BioSolutions
GSK
Johnson & Johnson
Pfizer
Merck
Sanofi
Major Type of Vaccines & Vaccination Covered in XYZResearch report:
Subunit vaccines
Live attenuated vaccines
Conjugate vaccines
Inactivated vaccines
Recombinant vector vaccines
Toxoid vaccines
Synthetic vaccines
Dendritic cell vaccines
Application Segments Covered in XYZResearch Market
Baby Vaccine
Adult Special Vaccine
Other

For any other requirements, please feel free to contact us and we will provide you customized report.